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ABSTRACT 
Background/Research Aims: Sudden cardiac arrest (SCA) and sudden cardiac death (SCD) are 
major public health issues that most often result in death and affect a significant number of 
adults. Implantable cardiac defibrillators (ICDs) are an important tool used in SCA/SCD 
prevention. Racial differences with respect to ICD firings have not been very well explored with 
only limited previous research on the topic. This study seeks to analyze a large dataset of patients 
with defibrillators by race and also build a risk model for ICD shock using Cox proportional 
hazards regression. 
Methods: Using data from the GRADE study, N= 1770 patients (1449 Whites and 321 African 
Americans) were initially compared by race for almost 80 baseline variables. N= 1524 patients 
(1275 Whites and 249 African Americans) had information on ICD shocks and were compared 
by race via Kaplan-Meier survival curves. A Cox proportional hazard regression analysis was 
performed to produce hazard ratios and evaluate each baseline characteristic with respect to 
defibrillator shock over time individually, followed by a multivariable model building process to 
examine race in the context of other significant covariates. Missing data was also examined in 
the variables comprising the final model and multiple imputations were performed for any 
variables deemed to have excessive missingness. 
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Results: Overall, African Americans were younger, had more nonischemic cardiomyopathy, had 
a higher prevalence of hypertension, smoked more, and had a lower ejection fraction than whites 
in the study. In comparing Kaplan-Meier survival curves, African Americans had a higher 
burden of shocks over time than whites by the end of the 5 year time period (p<0.01). Over 20 
variables were individually related to shock at 60 months in a Cox regression setting (including 
race). The final multivariable model consisted of seven variables: race (not statistically 
significant but forced into the model), ejection fraction, history of NSVT, antiarrhythmic 
medication, diagnosis, age, and BUN. One variable was found to have excessive missingness 
(BUN) and after performing multiple imputations, results were overall similar in the second 
analysis except race became statistically significant (p= 0.04, HR= 1.385) while BUN went from 
statistically significant to not.  
Conclusions: The public health impact of this study is in trying to build on the limited previous 
research and paint a more complete portrait of the relationship between race and appropriate 
defibrillator firings. After accounting for data missingness, race was found to be statistically 
significant in its relationship to ICD shock over time when adjusting for several additional 
covariates in the final multivariable model.   
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1.0  INTRODUCTION 
1.1 CARDIAC ARREST AND RACIAL DIFFERENCES 
Sudden cardiac arrest (SCA) and sudden cardiac death (SCD) are major public health 
problems with significant associated mortality. SCA is the abrupt loss of heart function in a person. 
This results in blood not flowing to the brain and other vital organs and is a medical emergency 
that can result in SCD within minutes if not treated.  
According to the American Heart Association in their 2015 update1, over 300,000 adults 
experienced an EMS-assisted, out-of-hospital cardiac arrest in the United States that year with an 
estimated risk-adjusted incidence rate of 76 per 100,000 people and a median age of 66 years old. 
For the patients lucky enough to be treated by EMS, the survival rate to hospital discharge was 
still only 10.6%. As these statistics illustrate, SCA/SCD are very serious issues that can end a 
person’s life very suddenly at a time when they still may have a significant amount of time left to 
live.  
SCA is normally preceded by an abnormal heart rhythm called an arrhythmia, which is a 
disturbance or abnormality in the heart’s electrical conduction system. Underlying causes and risk 
factors for a ventricular arrhythmia (the cause of most cardiac arrests) leading to SCA can include 
acute myocardial infarction (AMI), myocardial ischemia (lack of blood flow to the heart muscle), 
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severe electrolyte imbalances, drug toxicities, weakened left ventricular function, some heart 
rhythm issues like long Q-T syndrome, and congenital heart disease, among others.  
Previous studies have shown that there is an increased risk of SCA/SCD in the African 
American population1; 2; 3; 4; 5; 6 and also that African-Americans are less likely to survive an out of 
hospital cardiac arrest1; 2; 3; 4; 5; 6. These differences are most likely multifactorial3 and have 
traditionally been attributed to common cardiac risk factors in the African American population 
such as hypertension, left ventricular hypertrophy (or LVH, an enlargement/thickening of the left 
ventricle), heart failure, obesity, and diabetes mellitus. Socioeconomic status (SES) and genetic 
factors also very likely play a role in the differing burdens between populations.  
One example of a recent study illustrating these findings is the Oregon Sudden Unexpected 
Death Study (SUDS)2. This was a prospective observational study that took place in Portland, OR. 
Briefly, approximately 2000 patients (just under 200 African Americans) over a 10-year period 
who experienced a cardiac arrest were identified through paramedics, the state medical examiner, 
and state hospitals and compared by race for incidence rates, patient demographics, cardiac arrest 
circumstances, and clinical history. The study found that the burden of SCA was significantly 
higher among blacks compared to whites, with the age-adjusted incidence rates about two-fold as 
high for black men and women compared to whites. Blacks were also found to be younger at the 
time of their cardiac arrest and with a higher prearrest prevalence of hypertension, diabetes 
mellitus, and chronic renal insufficiency along with a higher prevalence of congestive heart failure 
(CHF) and LVH.  
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1.2 ICD THERAPY AND RACIAL DIFFERENCES 
One important and common method of treatment for preventing cardiac arrest and sudden 
death in those patients at risk is the implantable cardioverter defibrillator (ICD). In broad terms, 
the ICD is an implanted device that works by tracking a patient’s heart rate and rhythm and if 
something dangerous is detected, it delivers an electric shock to restore a normal heartbeat via 
the implanted wires that connect the device to the heart. ICDs are used as a form of both primary 
and secondary prevention for patients7; 8. Multiple studies have shown ICDs to be effective at 
decreasing patient mortality related to SCA in multiple situations7; 8 and the devices are a normal 
course of treatment for appropriate patients.    
The large majority of prior research studies examining and showing the effectiveness of 
ICDs in reducing the risk of SCD for patients have taken place in the context of mostly white 
cohorts, even though African Americans are at a higher risk for SCD than the general population. 
There is evidence to support a utilization disparity among African Americans who are eligible 
for an ICD9; 10, however, outcomes as they relate to race have not been as well explored.  
 There are a few previous studies of note to review pertaining to racial differences and 
ICDs. The Sudden Cardiac Death in Heart Failure (SCD-HeFT) study11 was a National Heart, 
Lung, and Blood institute sponsored, multi-center, randomized trial that demonstrated ICD 
therapy significantly improved survival compared with medical therapy alone in stable 
moderately symptomatic heart failure patients with a left ventricular ejection fraction (or LVEF, 
a measurement of the percentage of blood leaving the heart during each contraction) of <35%. A 
follow up study examined the outcomes in African Americans. Of the approximately 2500 
patients enrolled in the study, 17% were African American. Baseline demographics, clinical 
variables, SES, and long-term outcomes were compared according to race. African Americans 
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were found to be younger and had more non-ischemic heart failure (heart failure caused by 
something other than coronary artery disease), lower EF’s, worse NYHA functional class (a 
classification of the extent/severity of a patient’s heart failure based on their symptoms and 
limitations), and higher prevalence of a history of non-sustained ventricular tachycardia (NSVT, 
a ventricular arrhythmia). No significant differences were found in the rate of ICD discharge by 
race. Adjusted mortality risk was significantly higher in African Americans compared with 
whites but mortality was equally reduced in both race groups receiving ICD.  
The Multicenter Automatic Defibrillator Implantation Trial (MADIT-II) trial12 involved 
approximately 1200 subjects (8% African American) and examined the effectiveness of ICD 
therapy. The study found that ICDs were associated with a significant reduction in mortality and 
sudden cardiac death in whites but not blacks. Even after adjusting for relevant covariates, the 
ICD therapy/conventional therapy hazard ratios for total mortality and sudden cardiac death 
showed a trend toward benefit in whites but not African Americans.  
The Prospective Observational Study of Implantable Cardioverter-Defibrillators 
(PROSE-ICD) study10 was a multicenter prospective observational study of patients with systolic 
heart failure who underwent ICD implantation for primary prevention of SCD conducted from 
2003 to 2013. The study was conducted to determine the association between race and outcomes 
in this cohort of patients and the primary endpoint was appropriate ICD shock (a shock for a 
ventricular arrhythmia). There were just under 1200 patients in the study (~450 African 
Americans). African Americans were found to be at an increased risk of all-cause mortality 
without receiving an appropriate ICD shock, but not to be at increased risk for appropriate ICD 
shock. Ejection fraction appeared to explain over 20% of the excess risk of mortality in African 
Americans and diabetes and hypertension each were responsible for over 10%.   
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1.3 RESEARCH OBJECTIVES 
 This study seeks to build off of the limited previous research to examine the racial 
differences in patients with ICDs with respect to defibrillator shocks received. Many prior 
studies examining racial differences in SCA/SCD have only been descriptive in nature, and the 
prior research related specifically to racial differences and ICDs is also limited. This study looks 
to build a risk model relating race and appropriate ICD shock (defined as a shock for a 
ventricular arrhythmia) using Cox proportional hazards regression in examining a large cohort of 
patients with ICDs implanted. The main objective of the study is to build and use this model to 
further examine differences in shocks received by race.  
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2.0  METHODS 
2.1 STUDY SAMPLE 
The current study utilized data from the Genetic Risk Assessment of Defibrillator Events 
(GRADE) study. The GRADE study was a NHLBI sponsored prospective multi-center study that 
aimed to identify genetic modifiers of arrhythmic risk. The coordinating center was at the 
University of Pittsburgh Medical Center. Subjects with left ventricular systolic dysfunction 
(EF≤30%) and an ICD placed within the prior 6 months were enrolled. Recruitment took place 
from 2002 to 2010 and patients were followed annually for up to 5 years.  
2.1.1 Sample size 
There were initially 1823 patients included in the dataset. Thirty-three patients were 
missing a recorded race and were excluded from the analysis. An additional four patients had race 
of American Indian, ten patients had race of Asian, and four had race of “other”. Due to their 
extremely small sample sizes and the desire to compare whites and African Americans directly, 
these patients was also excluded. Of the remaining 1772 patients, two had ages under 18 and were 
excluded. The sample size of 1770 unique patients with race of either white or African American 
was used for all descriptive analyses (321 African Americans, ~18.1%). For all additional analyses, 
a total of 246 patients were missing the outcome of interest (appropriate defibrillator shock at 60 
months) and thus not included in the survival or model building process for a total N= 1524 patients 
(249 African Americans, ~16.3%).  
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2.2 PRIMARY OUTCOME 
The primary outcome for this study was appropriate ICD shock at 60 months. Some 
patients were followed for longer than 60 months, however 60 months was the last planned 
measurement for the study and thus was set as the maximum time frame used for the outcome 
variable. Measurements were recorded both as a continuous variable noting the time to shock in 
months, as well as a binary yes/no shock value at 60 months. 
2.2.1 Independent variables 
There were almost 80 independent variables that were measured at baseline included in the 
dataset that were initially analyzed in this study. The variables included patient demographics (ex. 
age, gender), disease status (ex. cardiac diagnosis, NYHA class), past medical histories (ex. history 
of hypertension, history of diabetes), baseline clinical values (ex. systolic blood pressure, weight), 
medication profile (ex. beta blocker, diuretics), baseline lab values (ex. sodium, creatinine), 
baseline EKG values (ex. QRS interval, LVH), baseline echocardiogram values (ex. left 
ventricular ejection fraction, valvular diagnoses), and baseline heart catheterization values (ex. 
CAD, various heart pressures).  
Comparisons between whites and African Americans were performed using Pearson’s chi-
squared test for all categorical variables and either t-test or Wilcoxon rank-sum test depending on 
normality for all continuous variables. Each variable is measured at baseline only and is not time 
dependent. Routine data maintenance was performed prior to the analysis with obvious data entry 
errors, such as incorrectly coded variables, and highly improbable medical/biological values, such 
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as negative numbers for a variable that cannot be negative or values several orders of magnitude 
away from all other values, dropped.  
2.3 STATISTICAL ANALYSIS 
2.3.1 Survival analysis 
In order to examine the data for any potential overall trends in shock differences between 
races, a standard survival analysis was conducted for the outcome variable with the 
event/censoring times. The survival function, S(t), was defined as the probability of an individual 
surviving, or not having an event, beyond time t (Mathematically, S(t)= P(T>t)). Survival curves 
were created with Kaplan-Meier estimates using the conditional survival probability formula:  
?̂?𝑆(𝑡𝑡) = � �1 − 𝑑𝑑𝑖𝑖
𝑛𝑛𝑖𝑖
�
𝑖𝑖=𝑡𝑡𝑖𝑖≤𝑡𝑡
 
where ni represents the number of subjects at risk at event time t(i) and di represents the number 
of events at event time t(i). Survival curves were compared by race using a standard log-rank test, 
where the null hypothesis was that both curves were equal (H0: S1(t)=S2(t) for all t). The test 
statistic was calculated as follows: 
𝑄𝑄 = [∑ (𝑑𝑑𝑖𝑖1 − 𝑒𝑒1𝚤𝚤�)𝑚𝑚𝑖𝑖=1 ]2
∑ 𝑣𝑣1𝚤𝚤�
𝑚𝑚
𝑖𝑖=1
 
where di1 represents the total number of deaths at event time t(i) in group 1, which follows a 
hypergeometric distribution with mean 𝑒𝑒1𝚤𝚤� = 𝑑𝑑𝑖𝑖(𝑛𝑛𝑖𝑖1𝑛𝑛𝑖𝑖 ) and variance 𝑣𝑣1𝚤𝚤� = 𝑑𝑑𝑖𝑖(𝑛𝑛𝑖𝑖−𝑑𝑑𝑖𝑖𝑛𝑛𝑖𝑖−1 )(𝑛𝑛1𝑖𝑖𝑛𝑛𝑖𝑖 )(1− 𝑛𝑛1𝑖𝑖𝑛𝑛𝑖𝑖 ). 
Q follows a chi-squared distribution with 1 degree of freedom.   
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2.3.2 Cox proportional hazards regression modeling 
 Cox proportional hazards regression models were used to model hazard functions and 
produce hazard ratios with regard to a patient receiving a defibrillator shock.  The hazard function, 
as the conditional instantaneous failure rate at time t, is defined as ℎ(𝑡𝑡) = lim
∆𝑡𝑡→0
𝑃𝑃(𝑡𝑡≤𝑇𝑇≤𝑡𝑡+∆𝑡𝑡|𝑇𝑇≥𝑡𝑡)
∆𝑡𝑡
. The 
Cox proportional hazard model is defined as  
ℎ(𝑡𝑡;𝑋𝑋) = ℎ0(𝑡𝑡)exp (𝑋𝑋𝑋𝑋) 
where h0(t) is the baseline hazard function with covariate matrix X and parameter vector β. The 
hazard ratio (HR) for defibrillator shock between units of a specified covariate is easily calculated 
from the model as 𝐻𝐻𝐻𝐻 = exp(𝑋𝑋). Of note, continuous covariates were centered at their mean to 
improve interpretability prior to model building.  
Covariates were first tested univariably using Wald’s test to assess individual significance 
as related to defibrillator shock at 60 months. From there, two-variable models were built to 
examine all univariably significant variables plus race. This was done to explore the relationship 
between race and the outcome adjusting for each covariate individually. Again, the Wald test was 
used to assess both individual covariate and overall model significance. A p-value <0.10 was 
considered significant for both the univariable and two-variable models.  
After univariable and two-variable models were built, a multivariable model was 
constructed using a backwards stepwise selection process. Criterion for inclusion in the initial 
multivariable model was univariable significance at the p=0.10 level and also significance with 
race in the two-variable models. Variable removal was based on individual covariate Wald tests. 
A p-value>0.05 was considered not significant and eligible for removal. Covariates with the 
highest p-values were removed two at a time and the model was then rerun with two additional 
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variables removed. This process was repeated until all variables were statistically significant at the 
0.05 level. The partial likelihood ratio test was performed between each model to confirm the lack 
of statistical significance for the removed variables. As race was the main covariate of interest in 
this study, it was forced into the model regardless of statistical significance.  
Model diagnostics were performed on the final model. Overall model significance was 
assessed and the proportional hazards assumption was also tested. Additionally, multicollinearity 
between variables in the final model was assessed by VIF criteria.  
Briefly, VIF reflects the degree to which the variances of other coefficients are increased 
due to the inclusion of covariate xj. It is calculated as 𝑉𝑉𝑉𝑉𝑉𝑉𝑗𝑗 = 11−𝑅𝑅𝑗𝑗2 , 𝑗𝑗 = 1,2, … , 𝑘𝑘 where Rj2 is the 
squared multiple correlation coefficient based on regressing xj on the remaining k-1 predictors. A 
VIF of around 1 corresponds to no effect and a VIF larger than 10 was deemed to be of concern.   
2.3.3 Missing data 
Data missingness was examined for the variables that comprised the final multivariable 
model. Missing data are commonly categorized in three ways with terminology first conceived by 
Rubin13: Missing completely at random (MCAR), missing at random (MAR), or missing not at 
random (MNAR).  
For missing data to be MCAR, it must be totally random and independent of all observed 
and unobserved values. Formally (following notation from Little and Rubin)14, Let Y = (yij) denote 
an (n x K) rectangular dataset without missing values, with the ith row yi = (yi1,…,yiK) where yij is 
the value of variable Yj for subject i. With missing data, define the missing-data indicator matrix 
M = (mij), such that mij = 1 if yij is missing and mij = 0 if yij is present. The matrix M then defines 
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the pattern of missing data. The missing data mechanism is characterized by the conditional 
distribution of M given Y, say f(M|Y,φ), where φ denotes unknown parameters. If missingness does 
not depend on the values of the data Y, missing or observed, that is, if f(M|Y,φ) = f(M|φ) for all Y, 
φ, the data are MCAR.  
Missing data are MAR if there is a relationship between these data and observed values, 
but no relationship with unobserved values. Formally, now let Yobs denote the observed 
components or entries of Y and Ymiss the missing components. Then if missingness depends only 
on the components Yobs of Y that are observed, and not on the components that are missing, that is, 
f(M|Y,φ) = f(M|Yobs,φ) for all Ymiss, φ, the data are MAR.  
Finally, missing data are MNAR if they are neither MCAR or MAR. In this case, 
missingness is not independent and depends on more than the observed components. It depends 
on the unobserved values, such as the missing observations themselves. Valid estimation then 
requires that the missing-data mechanism be modeled as part of the estimation process.  
 Missingness that is truly MCAR can effectively be ignored because the missing data are 
simply a random sample of the original sample and analyses of the complete cases will be valid 
and unbiased (although will have lower statistical power due to the decreased sample size)14; 15; 16. 
MCAR was informally examined in this study by looking at the association between missingness 
for a certain variable in terms of the other variables in the model and was also formally tested with 
Little’s test17. There is no test to distinguish between MAR and MNAR as this would depend on 
knowing the missing values themselves. 
Both statistical packages used for this analysis, R and Stata, treat missing data the same- 
by using complete case analysis or listwise deletion. These are two terms that mean that any 
observations with any missing values for the variables used in the model are automatically 
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dropped. Excessive missingness in any variable therefore can become a problem by limiting the 
amount of information being used in the analysis. This will decrease the statistical power and 
precision and possibly introduce bias if the missing data are not MCAR, as well as lead to larger 
standard errors14; 15; 16. All of these issues can lead to incorrect results and inferences.  
2.3.4 Multiple imputation 
There are several common ways to deal with missing data besides complete case analysis. 
Another common approach is to impute, or fill in, missing values. Single imputation techniques, 
such as filling in the mean, “hot deck”, or regression prediction, involve using the observed values 
to try to fill in a best guess for the missing values and then the analysis is carried forward in the 
usual way with both the observed and imputed observations. The major issue with single 
imputation, however, is that it does not take into account the uncertainty of the estimates which 
can lead to underestimates of standard errors14; 15; 16. This in turn affects p-values and confidence 
intervals. Variances for the variables with missing data tend to be underestimated as well and can 
lead to biased estimates of parameters15; 16. 
The solution to this problem is multiple imputation, which is appropriate for many 
situations including this study- an observational study that has covariates with missing 
observations18. Multiple imputation does account for the uncertainty in the estimates and produces 
parameter estimates that are approximately unbiased with correct standard errors15; 16. Multiple 
imputation follows a similar strategy to single imputation, but repeats the imputation process to 
simulate the missing data more than once. Data are assumed to be MAR under this approach. In 
general, there are three steps that are completed in this process: 
1. M complete datasets are generated under the chosen imputation model.  
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2. The Cox proportional hazard regression model is run separately on each imputed 
dataset m=1,2,…,M. 
3. The results from each analysis are pooled together to give a single model result.  
This process was first developed by Rubin (1987).  
Briefly, overall parameter estimates are created by taking the mean of all parameter 
estimates from the individual analyses of each imputed dataset. Overall standard error estimates 
are created in a few steps. First, the ‘within’ variance is created by taking the average of the squared 
standard errors in each analysis. The ‘between’ variance is the sample variance of the parameter 
estimates across the several analyses. One expression of the formula for combining the ‘between’ 
and ‘within’ variances given by Allison is as follows15:  
�
1
𝑀𝑀
� 𝑠𝑠𝑚𝑚2
𝑀𝑀
𝑚𝑚=1
+ (1 + 1
𝑀𝑀
)( 1
𝑀𝑀− 1)� (𝑏𝑏𝑚𝑚 − 𝑏𝑏�)2𝑀𝑀𝑚𝑚=1  
where M is the number of datasets, sm is the standard error in the mth dataset, and bm is the 
parameter estimated in the mth dataset.  
 For this study, the multiple imputation process was carried out in Stata using the mi 
package for any variable that needed to be imputed and any imputation was only carried out one 
variable at a time. Most literature, for example Rubin (1987), suggests that M=5 is sufficient to 
obtain valid inference (corresponding to asymptotic relative efficiency of 95% for 50% 
information missing). Increasing number of imputations produces increasing asymptotic 
efficiency15 and M=20 imputations was chosen for this study.  
The specific imputation method used was based on the type of variable that needed to be 
imputed, for example linear regression was used for any continuous variables with excessive 
missingness or logistic regression for any binary variables. The other variables comprising the 
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final model were chosen as the predictor variables for any imputation models. Briefly, each 
imputation in step 1 uses a slightly different regression model by modeling the coefficients from 
their own distributions. So the assigned values for the missing data are slightly different in each 
imputation to account for the inherent uncertainty in the estimates, and when the imputations are 
combined this uncertainty is taken into account.  
 15 
3.0  RESULTS 
3.1 DESCRIPTIVE ANALYSIS 
3.1.1 Primary outcome 
A total of 314 patients (20.6%) experienced a defibrillator shock by 60 months. Table 1 
shows the events broken down by race. Just under 25% of African Americans received a shock 
and almost 20% of whites were shocked.  
Table 1. Proportion of patients experiencing shock at 60 months by race 
Shock at 60 months Total (N=1,524) White (n=1,275) AA (n=249) 
No 1,210 (79.4%) 1,021 (80.1%) 189 (75.9%) 
Yes 314 (20.6%) 254 (19.9%) 60 (24.1%) 
 
Among all individuals who received shocks, the average time to shock was 17.5 months 
with a standard deviation of 15.1 months. Whites were shocked at an average of 17.5 months and 
African Americans at 17.7 months. Table 2 shows time to shock broken down by race and Figure 
1 illustrates these results as a histogram. 
Table 2. Mean time to shock (in months) by race 
 Total (N=314) 
Mean (SD) 
White (n=254) 
Mean (SD) 
AA (n=60) 
Mean (SD) 
Time to shock (mo.) 17.5 (15.1) 17.5 (15.1) 17.7 (14.7) 
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Figure 1. Histogram of time to shock by race 
3.1.2 Independent variables 
Each independent variable analyzed is presented in the tables below, grouped by variable 
category. Table 3 shows baseline patient demographics and disease status broken down by race. 
African Americans had a higher proportion of females and were younger overall. Whites had a 
higher proportion of patients with ischemic cardiomyopathy. NYHA class was also different by 
race.  
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Table 3. Patient Baseline Demographics and Disease Status 
Covariate Total (N=1770) White (n=1449) AA (n=321) P-value 
 N (%) n (%) n (%)  
Gender    <0.001 
   Male 1405 (79.4%) 1182 (81.6%) 223 (69.5%)  
   Female 365 (20.6%) 267 (18.4%) 98 (30.5%)  
Dx    <0.001 
   Ischemic Cardiomyopathy 1240 (70.1%) 1084 (74.9%) 156 (48.4%)  
   Idiopathic Cardiomyopathy 396 (22.4%) 259 (17.9%) 137 (42.5%)  
   Myocarditis/Other 133 (7.5%) 105 (7.2%) 28 (8.7%)  
NYHA Class    0.04 
   1 230 (13.3%) 181 (12.8%) 49 (15.4%)  
   2 950 (55.0%) 789 (55.9%) 161 (50.9%)  
   3 529 (30.6%) 422 (29.9%) 107 (33.6%)  
   4 19 (1.1%) 19 (1.3%) 0 (0%)  
Device Type    <0.001 
   ICD 73 (4.1%) 62 (4.3%) 11 (3.4%)  
   Single chamber 396 (22.5%) 288 (20.0%) 108 (33.8%)  
   Dual chamber 502 (28.5%) 443 (30.7%) 59 (18.4%)  
   ICD/BiV 790 (44.9%) 648 (45.0%) 142 (44.4%)  
     
 Mean (SD) Mean (SD) Mean (SD)  
Age (Years) 62.6 (12.2) 63.8 (11.6) 57.1 (13.4) <0.001 
 
 
Table 4 shows patient past medical histories by race. African Americans had a higher 
prevalence of hypertension and current smokers, but diabetes showed no statistically significant 
difference by race. Whites had a higher prevalence of prior heart attacks (MI).  
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Table 4. Patient Past Medical Histories 
Covariate Total (N=1770) White (n=1449) AA (n=321) P-value 
 N (%) n (%) n (%)  
Hx Myocardial Infarction    <0.001 
   No 812 (46.0%) 614 (42.5%) 198 (61.7%)  
   Yes 954 (54.0%) 831 (57.5%) 123 (38.3%)  
Hx Diabetes Mellitus    0.32 
   No 1134 (64.1%) 936 (64.6%) 198 (61.7%)  
   Yes 635 (35.9%) 512 (35.4%) 123 (38.3%)  
Hx Hypertension    <0.001 
   No 615 (34.8%) 570 (39.4%) 45 (14.0%)  
   Yes 1154 (65.2%) 878 (60.6%) 276 (86.0%)  
Hx Hypercholesterolemia    <0.001 
   No 609 (34.5%) 468 (32.4%) 141 (43.8%)  
   Yes 1156 (65.5%) 976 (67.6%) 180 (56.2%)  
Hx Smoking    0.81 
   No 832 (47.1%) 680 (47.0%) 152 (47.5%)  
   Yes 936 (52.9%) 768 (53.0%) 168 (52.5%)  
Current Smoker    <0.01 
   No 789 (80.0%) 660 (81.8%) 129 (72.1%)  
   Yes 197 (20.0%) 147 (18.2%) 50 (27.9%)  
Hx PVD    0.16 
   No 1607 (91.1%) 1309 (90.7%) 298 (93.1%)  
   Yes 157 (8.9%) 135 (9.3%) 22 (6.9%)  
Hx Atrial Tachycardia    <0.01 
   No 1098 (62.4%) 875 (60.7%) 223 (70.1%)  
   Yes 661 (37.6%) 566 (39.3%) 95 (29.9%)  
FHx Sudden Death    0.90 
   No 1313 (74.4%) 1075 (74.5%) 238 (74.1%)  
   Yes 451 (25.6%) 368 (25.5%) 83 (25.9%)  
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Table 4 Continued 
Hx Syncope    <0.001 
   No 1269 (71.7%) 1073 (74.1%) 196 (61.1%)  
   Yes 500 (28.3%) 375 (25.9%) 125 (38.9%)  
Hx SVT    0.79 
   No 1362 (77.1%) 1117 (77.2%) 245 (76.6%)  
   Yes 404 (22.9%) 329 (22.8%) 75 (23.4%)  
Hx NSVT    0.31 
   No 1054 (59.7%) 871 (60.3%) 183 (57.2%)  
   Yes 711 (40.3%) 574 (39.7%) 137 (42.8%)  
Hx Ablation    0.08 
   No 1596 (90.2%) 1298 (89.6%) 298 (92.8%)  
   Yes 173 (9.8%) 150 (10.4%) 23 (7.2%)  
Hx CABG    <0.001 
   No 1141 (64.5%) 875 (60.4%) 266 (82.9%)  
   Yes 627 (35.5%) 572 (39.6%) 55 (17.1%)  
Hx Valve    0.23 
   No 1619 (91.7%) 1321 (91.4%) 298 (93.4%)  
   Yes 146 (8.3%) 125 (8.6%) 21 (6.6%)  
Prior Shock    0.02 
   No 1414 (80.4%) 1173 (81.5%) 241 (75.5%)  
   Yes 345 (19.6%) 267 (18.5%) 78 (24.5%)  
     
Mean (SD) Mean (SD) Mean (SD)   
Pack Years 45.4 (47.8) 47.1 (43.9) 38.9 (60.2) <0.001 
# of Episodes 5.0 (10.7) 5.2 (11.4) 4.6 (8.8) 0.14 
# of Grafts 3.4 (1.4) 3.5 (1.4) 3.1 (1.3) 0.08 
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 Table 5 shows patient vital signs by race. African Americans had higher blood pressures 
and baseline heart rate but weight was not different by race.  
 
Table 5. Patient Baseline Vital Signs 
Covariate Total (N=1770) White (n=1449) AA (n=321) P-value 
 Mean (SD) Mean (SD) Mean (SD)  
Heart Rate 73.0 (12.4) 72.5 (12.6) 74.9 (11.3) <0.01 
SBP 119.8 (19.3) 118.9 (18.5) 123.6 (22.3) <0.01 
DBP 71.5 (11.8) 70.6 (11.4) 75.4 (13.0) <0.001 
Weight 197.2 (48.6) 196.1 (46.0) 202.2 (58.7) 0.08 
Height 68.7 (3.8) 68.8 (3.7) 68.2 (4.3) <0.01 
 
 
 Table 6 highlights patient’s medication profiles. A higher proportion of African Americans 
were on beta blockers and diuretics while there was no difference by race for antiarrhythmic 
medications.  
Table 6. Patient Baseline Medications 
Covariate Total (N=1770) White (n=1449) AA (n=321) P-value 
 N (%) n (%) n (%)  
ACE    0.02 
   No 595 (33.8%) 469 (32.5%) 126 (39.4%)  
   Yes 1167 (66.2%) 973 (67.5%) 194 (60.6%)  
A2 Blocker    0.48 
   No 1498 (85.0%) 1230 (85.3%) 268 (83.8%)  
   Yes 264 (15.0%) 212 (14.7%) 52 (16.2%)  
Beta blocker    0.01 
   No 261 (14.8%) 228 (15.8%) 33 (10.3%)  
   Yes 1504 (85.2%) 1217 (84.2%) 287 (89.7%)  
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Table 6 Continued 
Aldactone    <0.001 
   No 1289 (73.0%) 1098 (76.0%) 191 (59.5%)  
   Yes 476 (27.0%) 346 (24.0%) 130 (40.5%)  
Antiarrhythmic    0.11 
   No 1381 (78.2%) 1119 (77.5%) 262 (81.6%)  
   Yes 384 (21.8%) 325 (22.5%) 59 (18.4%)  
Diuretic    <0.01 
   No 478 (27.1%) 412 (28.6%) 66 (20.6%)  
   Yes 1285 (72.9%) 1030 (71.4%) 255 (79.4%)  
Digoxin    0.01 
   No 995 (56.6%) 794 (55.2%) 201 (62.8%)  
   Yes 763 (43.4%) 644 (44.8%) 119 (37.2%)  
Nitrates    0.13 
   No 901 (74.5%) 724 (75.5%) 177 (70.8%)  
   Yes 308 (25.5%) 235 (24.5%) 73 (29.2%)  
Hydralazine    <0.001 
   No 1090 (92.7%) 898 (97.1%) 192 (76.5%)  
   Yes 86 (7.3%) 27 (2.9%) 59 (23.5%)  
 
 Table 7 shows patient laboratory values by race. African Americans had higher creatinine 
but lower BUN which seems to paint a mixed picture about any differences in kidney function.  
Table 7. Patient Baseline Laboratory Values 
Covariate Total (N=1770) White (n=1449) AA (n=321) P-value 
 Mean (SD) Mean (SD) Mean (SD)  
Ca 9.1 (0.8) 9.0 (0.8) 9.2 (0.6) 0.01 
Mg 1.9 (0.3) 1.9 (0.3) 1.8 (0.3) <0.01 
Na 138.2 (3.2) 138.2 (3.2) 138.1 (3.2) 0.56 
Creat 1.4 (1.0) 1.4 (1.0) 1.5 (1.3) 0.01 
BUN 23.6 (13.2) 24.0 (13.0) 22.1 (13.8) <0.001 
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 Baseline EKG values by race are shown in Table 8. Whites had a higher proportion of atrial 
fibrillation, and African Americans had a higher proportion of LVH.  
 
Table 8. Patient Baseline EKG Values 
Covariate Total (N=1770) White (n=1449) AA (n=321) P-value 
 N (%) n (%) n (%)  
Atrial Fibrillation    0.02 
   No 1473 (90.3%) 1195 (89.4%) 278 (93.9%)  
   Yes 159 (9.7%) 141 (10.6%) 18 (6.1%)  
LVH    <0.001 
   No 1483 (91.2%) 1245 (93.6%) 238 (80.4%)  
   Yes 143 (8.8%) 85 (6.4%) 58 (19.6%)  
RVH    0.31 
   No 1615 (99.1%) 1323 (99.2%) 292 (98.6%)  
   Yes 14 (0.9%) 10 (0.8%) 4 (1.4%)  
AV Block    0.67 
   No 1451 (89.1%) 1186 (89.0%) 265 (89.8%)  
   Yes 177 (10.9%) 147 (11.0%) 30 (10.2%)  
RBBB    0.45 
   No 1517 (93.2%) 1239 (93.0%) 278 (94.2%)  
   Yes 110 (6.8%) 93 (7.0%) 17 (5.8%)  
LBBB    0.10 
   No 1407 (86.5%) 1143 (85.9%) 264 (89.5%)  
   Yes 219 (13.5%) 188 (14.1%) 31 (10.5%)  
     
 Mean (SD) Mean (SD) Mean (SD)  
PR 169.3 (44.7) 170.0 (45.6) 166.6 (41.3) 0.25 
QRS 132.2 (44.1) 134.8 (42.9) 120.5 (47.6) <0.001 
QTC 473.0 (53.4) 472.6 (53.4) 474.6 (53.5) 0.57 
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 Table 9 shows baseline echocardiogram values by race. African Americans had a lower 
left ventricular ejection fraction and higher proportion of patients with a valvular diagnosis.  
 
Table 9. Patient Baseline Echocardiogram Values 
Covariate Total (N=1770) White (n=1449) AA (n=321) P-value 
 N (%) n (%) n (%)  
RV Enlarged    <0.001 
   No 1008 (79.3%) 891 (81.1%) 117 (68.0%)  
   Yes 263 (20.7%) 208 (18.9%) 55 (32.0%)  
RV Hypokinetic    0.04 
   No 1011 (79.2%) 885 (80.2%) 126 (73.3%)  
   Yes 265 (20.8%) 219 (19.8%) 46 (26.7%)  
Pleural Effusion    0.01 
   No 1166 (91.0%) 1019 (91.8%) 147 (85.5%)  
   Yes 116 (9.0%) 91 (8.2%) 25 (14.5%)  
Valvular Dx    0.02 
   No 375 (28.7%) 339 (29.9%) 36 (20.9%)  
   Yes 931 (71.3%) 795 (70.1%) 136 (79.1%)  
     
 Mean (SD) Mean (SD) Mean (SD)  
LVEF 0.21 (0.06) 0.21 (0.06) 0.19 (0.07) <0.001 
LV Diastole 6.3 (1.0) 6.3 (1.0) 6.6 (1.0) <0.01 
LV Systole 5.4 (1.1) 5.4 (1.1) 5.6 (1.2) 0.04 
Septum 2.1 (2.9) 2.2 (3.0) 1.4 (2.0) 0.08 
Post Wall 1.9 (2.6) 2.0 (2.7) 1.3 (1.4) 0.03 
LA Diameter 4.7 (1.0) 4.7 (1.0) 4.6 (1.0) 0.08 
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 Finally, Table 10 shows heart catheterization values by race. Whites had a significantly 
higher proportion of coronary artery disease.  
 
Table 10. Patient Baseline Heart Catheterization Values 
Covariate Total (N=1770) White (n=1449) AA (n=321) P-value 
 N (%) n (%) n (%)  
CAD    <0.001 
   No 124 (16.4%) 84 (13.0%) 40 (35.1%)  
   Yes 637 (83.6%) 563 (87.0%) 74 (64.9%)  
     
 Mean (SD) Mean (SD) Mean (SD)  
RA 9.2 (5.3) 9.0 (5.3) 10.3 (5.7) 0.29 
RV Systolic 46.5 (16.9) 46.1 (17.0) 50.0 (15.1) 0.26 
RV Diastolic 9.7 (6.4) 9.8 (6.6) 9.3 (4.9) 0.74 
PA Systolic 46.7 (17.5) 46.4 (17.5) 49.4 (17.3) 0.40 
PA Diastolic 21.8 (9.0) 21.6 (9.1) 23.8 (8.2) 0.18 
PA Mean 31.0 (10.7) 30.8 (10.7) 32.2 (11.0) 0.59 
PCWP 20.6 (8.6) 20.4 (8.6) 22.8 (8.0) 0.23 
CO 4.6 (1.6) 4.6 (1.6) 4.2 (1.5) 0.17 
CI 2.3 (0.8) 2.3 (0.8) 2.2 (0.8) 0.31 
PA Sat 61.0 (10.1) 61.5 (10.0) 56.6 (9.8) 0.04 
 
3.2 SURVIVAL ANALYSIS 
 Figure 2 shows the Kaplan-Meier survival curves for appropriate defibrillator shock by 
race. African-Americans had a higher burden of shocks over time. A log rank test shows a 
statistically significant difference in the curves by race (p<0.01). The curves seem to follow a 
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similar pattern out to approximately 10-15 months with African Americans suffering a slightly 
higher burden of shocks, however after that point the curves begin to show increasing separation 
all the way to the study endpoint at 60 months.  
 
Figure 2. Shock burden over time by race. Event is appropriate shock up to 60 months. P<0.01.  
3.3 COX PROPORTIONAL HAZARD REGRESSION MODELING 
3.3.1 Univariable analysis and two-variable models 
 All 77 independent variables were tested in univariable Cox regressions to examine their 
individual statistical significance related to appropriate shock. Of these, 23 variables were 
statistically significant at the 0.10 level. Table 11 displays each statistically significant variable. 
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Of note, race was found to be statistically significant in the univariable models with a hazard 
ratio of ~1.5 (higher risk in African Americans).  
Table 11. Significant variables (p<0.10) for univariable Cox regressions 
Covariate Univariable p-value Hazard ratio 95% CI 
LVEF <0.001 0.010 (0.001,0.064) 
Hx SVT <0.001 1.725 (1.361,2.187) 
Hx NSVT <0.001 1.560 (1.250,1.947) 
Antiarrhythmics <0.001 1.753 (1.374,2.236) 
Prior shock <0.001 2.228 (1.748,2.840) 
Diagnosis <0.001   
LV diastole <0.001 1.605 (1.395,1.847) 
LV systole <0.001 1.500 (1.317,1.708) 
SBP <0.01 0.990 (0.984,0.996) 
Race <0.01 1.522 (1.147,2.019) 
Gender 0.01 0.631 (0.459,0.867) 
Age 0.01 0.987 (0.978,0.996) 
BUN 0.01 1.012 (1.003,1.021) 
ACE 0.02 0.755 (0.598,0.951) 
Aldactone 0.03 1.319 (1.036,1.679) 
DBP 0.03 0.989 (0.979,0.999) 
Digoxin 0.03 1.282 (1.027,1.6) 
RV enlarged 0.03 1.374 (1.031,1.833) 
Hx of syncope 0.03 1.307 (1.020,1.675) 
Nitrates 0.04 1.399 (1.018,1.923) 
Na 0.04 0.958 (0.920,0.998) 
Diuretics 0.04 1.308 (1.007,1.698) 
Height 0.10 1.026 (0.996,1.057) 
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 Table 12 gives the results of the two-variable model building process sorted by covariate 
p-value. For this step, the height variable was combined with weight to form BMI as BMI is a 
more clinically meaningful measure than height alone. In each of the 23 two-variable models built 
except three, both race and the covariate were statistically significant. Two covariates (LV diastole, 
LV systole) removed the race effect and one covariate (BMI) was itself not significant. These three 
variables were dropped from consideration for multivariable model building.  
Table 12. Two-variable model building process 
Covariate Overall model p-value (Wald) Covariate p-value Race p-value 
LVEF <0.001 <0.001 0.04 
Hx SVT <0.001 <0.001 <0.01 
Hx NSVT <0.001 <0.001 0.01 
Antiarrhythmics <0.001 <0.001 <0.01 
Prior shock <0.001 <0.001 0.01 
LV diastole <0.001 <0.001 0.23 
LV systole <0.001 <0.001 0.13 
SBP <0.001 <0.01 <0.01 
Gender <0.001 <0.01 <0.01 
DBP <0.001 <0.01 <0.01 
BUN <0.01 <0.01 0.02 
Age <0.01 0.02 0.01 
Digoxin <0.01 0.02 <0.01 
ACE <0.01 0.03 <0.01 
Na 0.02 0.04 0.04 
Nitrates 0.01 0.05 0.02 
Hx of syncope <0.01 0.05 <0.01 
RV enlarged <0.01 0.05 0.03 
Diuretics <0.01 0.06 <0.01 
Aldactone <0.01 0.08 0.01 
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Table 12 Continued 
Diagnosis <0.001 0.08 <0.01 
BMI 0.02 0.96 <0.01 
 
3.3.2 Multivariable model building 
After completing the model building process, the final model consisted of seven variables. 
These are displayed in Table 13 along with associated hazard ratios and p-values in the final model. 
Race was not statistically significant when adjusting for the other variables in the model. The 
hazard ratio of ~1.3 showed a higher adjusted risk of shock for African Americans. The other 
variables in the final model that were found to be significantly associated with appropriate shock 
over time were EF, personal history of NSVT, antiarrhythmic medication, cardiac diagnosis, age, 
and blood urea nitrogen (BUN, a measure of kidney function).  
Table 13. Final multivariable model with p-values 
Covariate HR 95% CI p-value 
Race 1.282 (0.903,1.820) 0.17 
LVEF 0.010 (0.001,0.106) <0.001 
Hx NSVT 1.435 (1.091,1.888) 0.01 
Antiarrhythmics 1.721 (1.274,2.327) <0.001 
Diagnosis(2) 0.709 (0.488,1.029) 0.07* 
Diagnosis(3) 0.493 (0.256,0.949) 0.03* 
Age 0.981 (0.969,0.994) <0.01 
BUN 1.014 (1.004,1.024) <0.01 
*Overall diagnosis p-value is 0.04 
The final model was overall statistically significant- confirmed with p<0.001 for the 
likelihood ratio test. The proportional hazards assumption was met (p=0.77). There were no 
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statistical issues with multicollinearity between variables in the final model. Table 14 shows 
individual VIF values for each variable in the final model. The mean VIF was 1.10 for all variables. 
Table 14. VIF for each variable in final model  
Covariate VIF 
Race 1.10 
LVEF 1.08 
Hx NSVT 1.02 
Antiarrhythmics 1.02 
Diagnosis(2) 1.15 
Diagnosis(3) 1.09 
Age 1.26 
BUN 1.09 
3.4 ASSESSMENT OF MISSING DATA 
One variable in the final model (BUN) had an issue with excessive missingness. Of the 
1524 observations used in the model building process, 492 were missing this covariate (~32.3%). 
No other variable in the final model was missing more than 3% of its values.  
3.4.1 Testing for MCAR 
All variables in the final model were tested, and both LVEF and race were found to be 
significantly different by missingness in BUN. Both of these variables were also found to 
significantly predict missingness of BUN in a logistic regression setting. Finally, Little’s MCAR 
test confirmed that BUN was indeed not MCAR.  
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3.4.2 Multiple imputation 
Table 15 shows summary statistics for BUN under the first, tenth, and last imputation as 
compared to the original variable. Linear regression was used for each imputation as BUN is a 
continuous variable. The means and standard deviations of each of these imputations do not show 
any concerning departures from the original values. The max values are all very similar, however 
there is a wider range in the minimum values among these imputations.  
Table 15. BUN summary statistics under original, first, tenth, and last imputation 
Imputation N Mean Std. Dev. Min Max 
Original 1240 0.000 13.218 -22.270 66.431 
1 1742 -0.031 13.260 -32.369 66.431 
10 1742 0.021 13.581 -47.196 66.431 
20 1742 -0.182 13.341 -50.647 66.431 
 
Table 16 compares coefficients, standard errors, and p-values for each variable in the model 
between the original model and the imputed model. The most significant finding when comparing 
the two models is that race becomes statistically significant while BUN goes from being significant 
to not. The p-value for race decreased by 0.13 and the p-value for BUN increased by 0.07. 
Coefficients and standard errors are relatively stable between models with no large changes in any 
variable. Each standard error from the imputed model is slightly smaller than from the original 
model. The largest change in coefficient is in LVEF which changes by ~0.65 between models. No 
other coefficient changes by more than 0.09. The largest change in standard error is also in LVEF 
which changes by 0.21, while no other standard error changes by more than 0.04.  
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Table 16. Comparison of original model (O) vs multiple imputation model (MI) 
Coviariate Coeff (O) Coeff (MI) Std. Error (O) Std. Error (MI) p-value (O) p-value (MI) 
Race 0.248 0.326 0.179 0.155 0.17 0.04 
LVEF -4.615 -3.963 1.210 1.000 <0.001 <0.001 
Hx NSVT 0.361 0.369 0.140 0.117 0.01 <0.01 
Antiarrhythmics 0.543 0.527 0.154 0.129 <0.001 <0.001 
Diagnosis(2) -0.345 -0.382 0.190 0.155 0.07* 0.01 
Diagnosis(3) -0.708 -0.618 0.335 0.283 0.03* 0.03 
Age -0.019 -0.017 0.007 0.005 <0.01 <0.01 
BUN 0.014 0.009 0.005 0.005 0.01 0.08 
 *Diagnosis was overall significant in the original model (p=0.04) 
  
Table 17 shows the hazard ratios derived from the imputed model compared to those from 
the original model. Again, the values of the point estimates are relatively consistent between 
models with no large changes. The hazard ratio associated with race changes by only ~0.1. No 
other hazard ratio changes by more than ~0.05. Most confidence intervals are slightly more narrow 
for the imputed model than the original model. 
Table 17. Comparison of Hazard Ratios for original (O) and imputed (MI) models 
Covariate HR (O) 95% CI (O) HR (MI) 95% CI (MI) 
Race 1.282 (0.903,1.820) 1.385 (1.023,1.876) 
LVEF 0.010 (0.001,0.106) 0.019 (0.003,0.135) 
Hx NSVT 1.435 (1.091,1.888) 1.447 (1.149,1.821) 
Antiarrhythmics 1.721 (1.274,2.327) 1.694 (1.315,2.182) 
Diagnosis(2) 0.709 (0.488,1.029) 0.683 (0.503,0.926) 
Diagnosis(3) 0.493 (0.256,0.949) 0.539 (0.310,0.938) 
Age 0.981 (0.969,0.994) 0.983 (0.972,0.993) 
BUN 1.014 (1.004,1.024) 1.009 (0.999,1.020) 
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4.0  DISCUSSION 
In this cohort of patients with ICDs from the University of Pittsburgh GRADE study, 
African Americans received a statistically significant higher burden of appropriate shocks over a 
5-year period than whites. Because appropriate ICD shock occurs in the setting of a dangerous 
ventricular heart rhythm that would otherwise lead to SCA if not terminated, and it is known that 
African Americans have higher rates of SCA1; 2; 3; 4; 5; 6, the finding does seem plausible. 
Of 77 independent variables tested in relation to the outcome, 23 were found to be 
individually statistically significant in a Cox proportional hazards regression setting. Using these 
variables as the basis for a backwards stepwise multivariable model building process, the final 
model consisted of the following covariates: left ventricular ejection fraction, history of NSVT, 
antiarrhythmic medication, diagnosis, age, and BUN. Race was not statistically significant but was 
forced into the model. 
Missing data was found to be excessive in BUN and a multiple imputation procedure was 
performed to develop completed datasets. After analyzing and combining the simulated datasets, 
findings were similar for most covariates in terms of coefficients, hazard ratios and standard errors. 
One covariate (LVEF) did have slightly larger changes than the rest. Standard errors were slightly 
smaller and confidence intervals for hazard ratios in the imputed model were narrower than for the 
original model. Overall these findings seem to imply that the missing data did not introduce 
substantial bias into the original analysis (with the possible exception of LVEF), however the 
imputation of the missing data did increase the precision of the estimates.  
Two additional notable changes occurred as well in the imputed model. Race became 
statistically significant and BUN went from being statistically significant to not. While the changes 
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in p-value were not extremely large, they were enough to change the statistical significance. This 
is mostly likely due to a combination of the increased statistical power from having more 
observations, in addition to the (limited) previous bias in the original analysis being corrected. 
Even though the coefficients and standard errors for race and BUN did not change much between 
the two models, the somewhat larger potential bias in LVEF may be playing a role in the 
relationship between all of these variables and shock. Together these two factors decreased the 
variability of the estimates and increased the statistical precision enough to change the p-values. 
Overall, even though most changes were subtle, the multiple imputation process seems to be a 
worthwhile procedure in the analysis.  
In examining the hazard ratios, it can be seen that African American race, lower LVEF, 
personal history of NSVT, being on an antiarrhythmic medication, lower age, and higher BUN 
were all associated with an increased risk of defibrillator shock over the time period studied. 
Additionally, having a diagnosis of ischemic cardiomyopathy was associated with a higher hazard 
rate compared to both idiopathic cardiomyopathy and myocarditis/other. 
This study has both similarities and differences when compared to the results of prior 
research. Compared to whites, African Americans in this cohort were younger, had more non-
ischemic cardiomyopathy, lower EF, worse NYHA functional class, and more hypertension. These 
findings are similar to other cohorts studied with respect to both ICDs and SCA/SCD in general2; 
3; 4; 6; 10; 11; 12. One major difference and important finding from this study is that while neither the 
SCD-HeFT study nor the PROSE-ICD study found a differing burden of ICD shocks between 
whites and African Americans, this study did. This appears to be a new finding. 
Another important aspect of this study and one of its major strengths is that it examined a 
much larger set of independent variables than prior studies examining race and ICDs. Using such 
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a large number of variables has allowed for the relationship between appropriate shock and many 
more patient characteristics to be explored. The greater than 20 variables that were found to be 
individually statistically significant include variables that are commonly explored in the literature 
with respect to race and ICDs10; 11; 12, such as ejection fraction, age, gender, ischemic vs 
nonischemic cardiomyopathy diagnosis, blood pressure, and kidney function, but also variables 
that are much less commonly examined, if at all. Examples include antiarrhythmic medications, 
RV enlargement, serum sodium levels, and having a history of syncope or SVT. The two variable 
models allowed the race effect to be examined in the context of each variable individually. 
Multivariable model building with this many variables also allows for race to be adjusted for many 
more variables than prior studies, which provided greater insight into the relationship between race 
and appropriate shock. The seven variable final model, like the individual variable results, also 
includes a mix of covariates previously seen in the literature (LVEF, diagnosis, age, BUN) and 
two that are not as frequently seen (Hx NSVT and antiarrhythmic medication).  
4.1 PUBLIC HEALTH SIGNIFICANCE 
The public health significance of the findings of this study is in trying to build on the 
limited previous research and paint a more complete portrait of the relationship between race and 
appropriate defibrillator firings. An increased burden of appropriate defibrillator firings for 
African Americans is an important new finding because it has not been seen before in the literature, 
and also because this measurement is a surrogate for SCA/SCD. Patients who have a defibrillator 
firing are patients who would have otherwise gone into cardiac arrest and most likely died. 
Recurrent ventricular arrhythmias could affect the heart and rest of the body in negative ways, in 
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addition to the physical discomfort a patient receives from a shock. These patients may have other 
underlying medical issues related to their ventricular arrhythmias that need to be addressed. And 
defibrillators are not perfect devices so there is a risk of a patient dying without receiving the 
necessary shock. 
The race effect with respect to defibrillator firings over a five-year period has been adjusted 
for a large number of covariates to construct the final model. In practice this model could be used 
to assess those who may be at higher risk of receiving a shock, specifically with respect to a 
patient’s race, and these patients could have changes made to their care to account for this fact. 
This model also provides new insight into several patient characteristics that possibly should be 
given further consideration in a clinical setting when examining risk factors for a patient receiving 
a defibrillator shock.  
4.2 FUTURE CONSIDERATIONS 
Confounding and interactions were not examined in this analysis but would be very logical 
next steps to undertake. A dataset with this many covariates almost certainly is affected by certain 
variables confounding or modifying the effects of others. The multiple comparisons problem is 
another statistical issue to consider. Testing this many independent variables presents the issue of 
some of the findings of variable significance occurring simply by chance. A commonly used 
solution to this problem would be to introduce a Bonferroni correction to control the familywise 
error rate in the univariable models prior to multivariable model building.  
Some variables may be more clinically relevant than others or known to clinically affect 
others in meaningful ways. This analysis was carried out with a standard statistical model building 
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algorithm where all independent variables were equally considered in both the univariable and 
multivariable process. Future approaches could be more clinically or biologically inclined. The 
variables used could be limited to those most applicable to the “real world” of patient care or from 
a more biological point of view. Additionally, the large number of covariates as they relate to ICD 
shocks could be analyzed in specific subgroups, such as medical history alone or test/laboratory 
values alone.  
Another future consideration would be to examine missing data from the start of the 
analysis as opposed to only in the final model. While imputing a significant amount of variables 
(or another missing data method) may be very time consuming, it may yield different results or 
affect the analysis in other ways. The outcome variable could also be imputed. 
Examining patient mortality by race would be another logical next step, as almost every 
other previous study that has examined appropriate defibrillator firings has also examined patient 
mortality in some way. The GRADE dataset does include mortality data.  
4.3 CONCLUSION 
In conclusion, this study examined a very large set of covariates with respect to race and 
appropriate defibrillator firings in a cohort of patients with ICDs. The study has provided new 
insights that can be applied to patient care in hopes of identifying those at increased risk for ICD 
shock. This study has also provided a stepping stone for future research in an area with many 
opportunities for further exploration. SCA/SCD, and by extension appropriate ICD firing, are very 
serious public health issues and continuing to explore its underlying risk factors should be of great 
importance.  
 37 
BIBLIOGRAPHY 
1 MOZAFFARIAN, D.  et al. Heart disease and stroke statistics--2015 update: a report from 
the American Heart Association. Circulation, v. 131, n. 4, p. e29-322, Jan 2015. ISSN 
1524-4539. Disponível em: < http://www.ncbi.nlm.nih.gov/pubmed/25520374 >.  
 
2 REINIER, K.  et al. Distinctive Clinical Profile of Blacks Versus Whites Presenting With 
Sudden Cardiac Arrest. Circulation, v. 132, n. 5, p. 380-7, Aug 2015. ISSN 1524-4539. 
Disponível em: < http://www.ncbi.nlm.nih.gov/pubmed/26240262 >.  
 
3 FENDER, E. A.; HENRIKSON, C. A.; TERESHCHENKO, L. Racial differences in 
sudden cardiac death. J Electrocardiol, v. 47, n. 6, p. 815-8, 2014 Nov-Dec 2014. ISSN 
1532-8430. Disponível em: < http://www.ncbi.nlm.nih.gov/pubmed/25155390 >.  
 
4 COWIE, M. R.  et al. Out-of-hospital cardiac arrest: racial differences in outcome in 
Seattle. Am J Public Health, v. 83, n. 7, p. 955-9, Jul 1993. ISSN 0090-0036. Disponível 
em: < http://www.ncbi.nlm.nih.gov/pubmed/8328616 >.  
 
5 BECKER, L. B.  et al. Racial differences in the incidence of cardiac arrest and subsequent 
survival. The CPR Chicago Project. N Engl J Med, v. 329, n. 9, p. 600-6, Aug 1993. ISSN 
0028-4793. Disponível em: < http://www.ncbi.nlm.nih.gov/pubmed/8341333 >.  
 
6 WILDE, E. T.; ROBBINS, L. S.; PRESSLEY, J. C. Racial differences in out-of-hospital 
cardiac arrest survival and treatment. Emerg Med J, v. 29, n. 5, p. 415-9, May 2012. ISSN 
1472-0213. Disponível em: < http://www.ncbi.nlm.nih.gov/pubmed/21546508 >.  
 
7 DIMARCO , J. P. Implantable Cardioverter–Defibrillators. New England Journal of 
Medicine, v. 349, n. 19, p. 1836-1847,  2003.  Disponível em: < 
http://www.nejm.org/doi/full/10.1056/NEJMra035432 >.  
 
8 KADISH, A.; MEHRA, M. Heart failure devices: implantable cardioverter-defibrillators 
and biventricular pacing therapy. Circulation, v. 111, n. 24, p. 3327-35, Jun 2005. ISSN 
1524-4539. Disponível em: < http://www.ncbi.nlm.nih.gov/pubmed/15967863 >.  
 
9 THOMAS, K. L.  et al. Racial disparity in the utilization of implantable-cardioverter 
defibrillators among patients with prior myocardial infarction and an ejection fraction of 
<or=35%. Am J Cardiol, v. 100, n. 6, p. 924-9, Sep 2007. ISSN 0002-9149. Disponível 
em: < http://www.ncbi.nlm.nih.gov/pubmed/17826371 >.  
 
10 ZHANG, Y.  et al. Outcomes in African Americans undergoing cardioverter-defibrillator 
implantation for primary prevention of sudden cardiac death: findings from the Prospective 
Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD). Heart 
 38 
Rhythm, v. 11, n. 8, p. 1377-83, Aug 2014. ISSN 1556-3871. Disponível em: < 
http://www.ncbi.nlm.nih.gov/pubmed/24793459 >.  
 
11 MITCHELL, J. E.  et al. Outcome in African Americans and other minorities in the Sudden 
Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J, v. 155, n. 3, p. 501-6, Mar 
2008. ISSN 1097-6744. Disponível em: < http://www.ncbi.nlm.nih.gov/pubmed/18294487 
>.  
 
12 VOROBIOF, G.  et al. Effectiveness of the implantable cardioverter defibrillator in blacks 
versus whites (from MADIT-II). Am J Cardiol, v. 98, n. 10, p. 1383-6, Nov 2006. ISSN 
0002-9149. Disponível em: < http://www.ncbi.nlm.nih.gov/pubmed/17134634 >.  
 
13 RUBIN, D. Inference and Missing Data. Biometrika, v. 63, n. 3, p. 581-592,  1976.    
 
14 LITTLE, R.; RUBIN, D. Statistical Analysis with Missing Data. 2nd Edition.  Wiley, 
2002.     
 
15 ALLISON, P. Missing Data. In: MILLSAP, R. e MAYDEU-OLIVARES, A. (Ed.). The 
SAGE Handbook of Quantitative Methods in Psychology: SAGE Publications, 2009. 
cap. 4, p.72-89.   
 
16 DONDERS, A. R.  et al. Review: a gentle introduction to imputation of missing values. J 
Clin Epidemiol, v. 59, n. 10, p. 1087-91, Oct 2006. ISSN 0895-4356. Disponível em: < 
http://www.ncbi.nlm.nih.gov/pubmed/16980149 >.  
 
17 LITTLE, R. A Test of Missing Completely at Random for Multivariate Data with Missing 
Values. Journal of the American Statistical Association, v. 83, n. 404, p. 1198-1202,  
1988.    
 
18 KENWARD, M. G.; CARPENTER, J. Multiple imputation: current perspectives. Stat 
Methods Med Res, v. 16, n. 3, p. 199-218, Jun 2007. ISSN 0962-2802. Disponível em: < 
http://www.ncbi.nlm.nih.gov/pubmed/17621468 >.  
 
 
